The promise of a new clinical trial--intra-articular IL-1 receptor antagonist.

C. H. Evans, P. D. Robbins

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

Most rheumatic diseases resist traditional therapeutic interventions. Novel biologicals show considerable promise as antirheumatic agents but do not lend themselves to delivery as drugs. Gene therapy promises to harness the therapeutic potential of proteins by acting as a biological drug delivery system. Considerable progress has been made in the use of genes to treat animal models of RA, and a human trial of this technology is scheduled to begin this year.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalProceedings of the Association of American Physicians
Volume108
Issue number1
StatePublished - Jan 1996

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The promise of a new clinical trial--intra-articular IL-1 receptor antagonist.'. Together they form a unique fingerprint.

  • Cite this